flatreader
My Feed
Login
Sign Up
The Best GLP-1 Drug on the Market Is Even Better Than We Knew - Gizmodo
The Best GLP-1 Drug on the Market Is Even Better Than We Knew
Gizmodo
Tirzepatide significantly reduces cardiovascular risk in high-risk patients
News-Medical
Popular weight loss drug linked to key benefits for patients undergoing TAVR, PCI
Cardiovascular Business
Effects of tirzepatide, a dual GIP and GLP-1 receptor agonist, on blood pressure, cardiac function, and sympathetic nervous system in stroke-prone spontaneously hypertensive rats
Nature
Q&A: Tirzepatide Outperforms Dulaglutide in Cardiorenal Outcomes, With Steven Nissen, MD
Patient Care Online